000			02080nam a2200469 i 4500
999			_c273480 _d273480
001			on1043948909
003			OCoLC
005			20180813131624.0
006			m o d f
007			cr bn||||a||||
008			180713s2018 dcua ob f000 0 eng c
040			_aPUCPR _beng _erda _epn _cGPO _dGPO _dMvI
042			_apcc
043			_an-us---
074			_a1019-C-01 (online)
086	0		_aY 4.C 73/8:115-88
088			_aSerial no. 115-88 (United States. Congress. House. Committee on Energy and Commerce)
099			_aY 4.C 73/8:115-88
110	1		_aUnited States. _bCongress. _bHouse. _bCommittee on Energy and Commerce. _bSubcommittee on Health,
245	1	0	_aExamining the drug supply chain : _bhearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, December 13, 2017.
264		1	_aWashington : _bU.S. Government Publishing Office, _c2018.
300			_a1 online resource (vi, 320 pages) : _billustration
336			_btxt
337			_bc _2rdamedia
338			_bcr _2rdacarrier
500			_a"Serial No. 115-88."
500			_aCRDP Program record.
504			_aIncludes bibliographical references.
588			_aDescription based on online resource; title from PDF title page (govinfo, viewed July 13, 2018).
776	0	8	_iPrint version: _aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. _tExamining the drug supply chain _w(OCoLC)1043948698
856	4	0	_uhttps://purl.fdlp.gov/GPO/gpo105824
050		4	_aKF27 _b.E553 2017c
650		0	_aDrugs _xPrescribing _zUnited States.
650		0	_aPrescription pricing _zUnited States.
650		0	_aMedicine _xResearch _zUnited States.
650		0	_aGeneric drugs _xDevelopment _zUnited States.
650		0	_aCompetition _zUnited States.
650		0	_aConsumer protection _zUnited States.
650		0	_aHealth services accessibility _zUnited States.
655		7	_aLegislative hearings. _2lcgft
942			_2sudocs _c8